U.S., Jan. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07328022) titled 'Efficacy and Safety of Etoricoxib/Betamethasone Combination in Acute Bursitis, Tendinitis and Synovitis' on Dec. 28, 2025.
Brief Summary: Phase III, multicenter, prospective, randomized, double-blind, parallel-group study to evaluate the efficacy and safety of a fixed-dose combination of etoricoxib/betamethasone compared with etoricoxib alone in patients with an acute episode of bursitis, tendinitis, or synovitis affecting the shoulder, elbow, knee, or ankle.
Study Start Date: May 14, 2025
Study Type: INTERVENTIONAL
Condition:
Bursitis
Tendinitis
Synovitis
Intervention:
DRUG: Fixed Dose Etoricoxib + Betamethasone
One tablet of...